DE2329092A1 - N-substituierte prostaglandincarboxamide und verfahren zu deren herstellung - Google Patents
N-substituierte prostaglandincarboxamide und verfahren zu deren herstellungInfo
- Publication number
- DE2329092A1 DE2329092A1 DE2329092A DE2329092A DE2329092A1 DE 2329092 A1 DE2329092 A1 DE 2329092A1 DE 2329092 A DE2329092 A DE 2329092A DE 2329092 A DE2329092 A DE 2329092A DE 2329092 A1 DE2329092 A1 DE 2329092A1
- Authority
- DE
- Germany
- Prior art keywords
- radical
- carbon atoms
- double bond
- compound
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26051872A | 1972-06-07 | 1972-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2329092A1 true DE2329092A1 (de) | 1974-01-03 |
Family
ID=22989486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2329092A Ceased DE2329092A1 (de) | 1972-06-07 | 1973-06-07 | N-substituierte prostaglandincarboxamide und verfahren zu deren herstellung |
Country Status (24)
| Country | Link |
|---|---|
| JP (2) | JPS5715591B2 (https=) |
| AR (1) | AR207434A1 (https=) |
| AT (1) | AT340069B (https=) |
| BE (1) | BE800580A (https=) |
| CA (1) | CA985280A (https=) |
| CH (3) | CH593929A5 (https=) |
| CS (1) | CS200166B2 (https=) |
| DD (2) | DD109211A5 (https=) |
| DE (1) | DE2329092A1 (https=) |
| ES (3) | ES415611A1 (https=) |
| FI (1) | FI58327C (https=) |
| FR (2) | FR2187344B1 (https=) |
| GB (2) | GB1439512A (https=) |
| HU (3) | HU170491B (https=) |
| IE (1) | IE38058B1 (https=) |
| IL (2) | IL42385A (https=) |
| IN (1) | IN138966B (https=) |
| LU (1) | LU67754A1 (https=) |
| NL (2) | NL160814C (https=) |
| NO (2) | NO146538C (https=) |
| PH (2) | PH14204A (https=) |
| SE (3) | SE415883B (https=) |
| YU (1) | YU36498B (https=) |
| ZA (1) | ZA733763B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX3291E (es) * | 1975-04-23 | 1980-08-22 | Upjohn Co | Procedimiento para preparar analogos de prostaglandinas |
| US6395787B1 (en) * | 2000-02-08 | 2002-05-28 | Allergan Sales, Inc. | Ocular hypotensive lipids |
| US6476064B1 (en) * | 2001-06-13 | 2002-11-05 | Allergan, Inc. | Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3187043A (en) * | 1962-05-18 | 1965-06-01 | Monsanto Co | Monohalophosphonium halides |
-
1973
- 1973-01-01 AR AR248467A patent/AR207434A1/es active
- 1973-05-28 SE SE7307522A patent/SE415883B/xx unknown
- 1973-05-29 IL IL42385A patent/IL42385A/xx unknown
- 1973-05-29 CA CA172,672A patent/CA985280A/en not_active Expired
- 1973-05-29 GB GB4209675A patent/GB1439512A/en not_active Expired
- 1973-05-29 GB GB2561373A patent/GB1439511A/en not_active Expired
- 1973-05-30 FI FI1762/73A patent/FI58327C/fi active
- 1973-05-31 IN IN1278/CAL/73A patent/IN138966B/en unknown
- 1973-06-04 PH PH14689A patent/PH14204A/en unknown
- 1973-06-04 ZA ZA733763A patent/ZA733763B/xx unknown
- 1973-06-05 IE IE896/73A patent/IE38058B1/xx unknown
- 1973-06-06 ES ES415611A patent/ES415611A1/es not_active Expired
- 1973-06-06 HU HUPI476A patent/HU170491B/hu unknown
- 1973-06-06 NL NL7307867.A patent/NL160814C/xx not_active IP Right Cessation
- 1973-06-06 HU HUPI384A patent/HU170487B/hu unknown
- 1973-06-06 HU HUPI477A patent/HU170200B/hu unknown
- 1973-06-06 NO NO2379/73A patent/NO146538C/no unknown
- 1973-06-07 JP JP6435173A patent/JPS5715591B2/ja not_active Expired
- 1973-06-07 DE DE2329092A patent/DE2329092A1/de not_active Ceased
- 1973-06-07 CS CS734136A patent/CS200166B2/cs unknown
- 1973-06-07 CH CH831273A patent/CH593929A5/xx not_active IP Right Cessation
- 1973-06-07 DD DD171393A patent/DD109211A5/xx unknown
- 1973-06-07 YU YU01526/73A patent/YU36498B/xx unknown
- 1973-06-07 CH CH1535876A patent/CH591511A5/xx not_active IP Right Cessation
- 1973-06-07 AT AT504873A patent/AT340069B/de not_active IP Right Cessation
- 1973-06-07 LU LU67754A patent/LU67754A1/xx unknown
- 1973-06-07 FR FR7320753A patent/FR2187344B1/fr not_active Expired
- 1973-06-07 CH CH1535976A patent/CH605887A5/xx not_active IP Right Cessation
- 1973-06-07 BE BE1005125A patent/BE800580A/xx not_active IP Right Cessation
- 1973-06-07 DD DD180810*A patent/DD115687A5/xx unknown
-
1974
- 1974-03-11 NO NO740850A patent/NO142784C/no unknown
- 1974-09-26 ES ES430416A patent/ES430416A1/es not_active Expired
- 1974-09-26 ES ES430417A patent/ES430417A1/es not_active Expired
-
1975
- 1975-06-06 FR FR7517790A patent/FR2273814A1/fr active Granted
- 1975-06-25 PH PH17314A patent/PH13092A/en unknown
-
1976
- 1976-07-19 SE SE7608225A patent/SE7608225L/xx not_active Application Discontinuation
- 1976-07-19 SE SE7608224A patent/SE418744B/xx unknown
-
1977
- 1977-02-23 IL IL51525A patent/IL51525A0/xx unknown
-
1978
- 1978-12-14 NL NL7812163A patent/NL7812163A/xx not_active Application Discontinuation
-
1981
- 1981-06-10 JP JP8940881A patent/JPS5731692A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68904104T2 (de) | Phenol-substituierte gem-diphosphonat-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel. | |
| EP0059158B1 (de) | Azaprostacycline, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung | |
| DE2726619A1 (de) | Allylcarbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung | |
| EP0119949B1 (de) | Neue Carbacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| DE2318785A1 (de) | Prostansaeurederivate | |
| EP0036663B1 (de) | Oxiranbuttersäure-Derivate, ihre Herstellung und Verwendung, sowie diese enthaltende Arzneimittel | |
| DE2317019A1 (de) | Neue 4,5-didehydro-prostaglandine | |
| DE2904655A1 (de) | Prostacyclinanaloga | |
| DE2641823A1 (de) | Neue prostaglandin-analoga | |
| DE2365101A1 (de) | Neue prostansaeurederivate und verfahren zu ihrer herstellung | |
| DE2729960A1 (de) | Neue acetylenprostaglandine und verfahren zu ihrer herstellung | |
| DE2329092A1 (de) | N-substituierte prostaglandincarboxamide und verfahren zu deren herstellung | |
| DE2434133C2 (de) | 15,15-Äthylendioxy-Prostansäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| CH634831A5 (en) | Process for the preparation of optically active or racemic prostaglandins. | |
| EP0510154B1 (de) | 9-HALOGEN-11(Beta)-HYDROXY-PROSTAGLANDINDERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL | |
| DE2330333A1 (de) | 9-desoxy-prosta-5,9(10),13-triensaeurederivate | |
| DE2737808A1 (de) | 2-substituierte aryl-heterocyclische omega-pentanorprostaglandine | |
| DE2337630A1 (de) | Neue in 15-stellung substituierte prostansaeuren und ester davon, sowie verfahren zu ihrer herstellung | |
| DE2610503C2 (de) | Optisch aktive 13,14-Dehydro-11- desoxy-prostaglandine, Verfahren zu ihrer Herstellung und sie enthaltendes pharmazeutisches Mittel | |
| EP0015227B1 (de) | Neue Prostacyclin-Derivate und Verfahren zu ihrer Herstellung | |
| EP0057660B1 (de) | Neue Prostacyclin-Derivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
| DE3714965A1 (de) | 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate | |
| LU83992A1 (de) | Neue fluorprostacycline | |
| DE2524619A1 (de) | (dl)-13-substituierte sulfinyl- prostaglandinartige verbindungen und verfahren zu ihrer herstellung | |
| CH623570A5 (https=) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OD | Request for examination | ||
| 8131 | Rejection |